Back

Do Must-Access Prescription Drug Monitoring Programs (PDMPs) Affect Pain and Physical Impairment Outcomes in Older Adults?

Wetzel, M.; Howard, D. H.; Giordano, N. A.; Patrick, S. W.; Yarbrough, C. R.

2025-06-03 health policy
10.1101/2025.06.02.25328258 medRxiv
Show abstract

BackgroundState policies requiring clinicians to review prescription drug monitoring program (PDMP) databases have proliferated. Patient advocates warn that such policies may reduce quality of life for some patients. ObjectivesTo quantify the relationship between must-access PDMPs and pain and physical impairment outcomes. Research DesignUsing Health and Retirement Survey (HRS) data on older adults in the US from 2002-2021, we conducted a heterogeneity-robust difference-in-differences analysis. ResultsThe population included 34,431 individuals with an average age of 67. Must-access PDMPs were initially associated with 1.65 (95% CI: 0.43 - 2.87) to 3.52 (95% CI: 0.88 - 6.16) percentage point increases in the reports of frequent pain. However, the effect dissipated over time. Effects on the impairment outcomes were positive but statistically insignificant. ConclusionsMust-access PDMP policies are associated with an initial increase in frequent pain reported by older adults. No significant effects on physical impairment outcomes were found. Continued research examining the role of PDMPs on patient health outcomes is warranted.

Published in Medical Care Research and Review · not in our set (fewer than 10 published preprints to learn from) · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.